Efficacy and safety of peginterferon alfa-2a + RBV in cHCV/HIV- vs cHCV-infected patients: interim analysis of a multicenter German cohort

Detalles Bibliográficos
Autores principales: Baumgarten, A, Lutz, T, Kreckel, P, Wellmann, E, Alshuth, U, Mauss, S, Rockstroh, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112846/
http://dx.doi.org/10.1186/1758-2652-13-S4-O32
_version_ 1782205830785925120
author Baumgarten, A
Lutz, T
Kreckel, P
Wellmann, E
Alshuth, U
Mauss, S
Rockstroh, J
author_facet Baumgarten, A
Lutz, T
Kreckel, P
Wellmann, E
Alshuth, U
Mauss, S
Rockstroh, J
author_sort Baumgarten, A
collection PubMed
description
format Online
Article
Text
id pubmed-3112846
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31128462011-06-13 Efficacy and safety of peginterferon alfa-2a + RBV in cHCV/HIV- vs cHCV-infected patients: interim analysis of a multicenter German cohort Baumgarten, A Lutz, T Kreckel, P Wellmann, E Alshuth, U Mauss, S Rockstroh, J J Int AIDS Soc Oral Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3112846/ http://dx.doi.org/10.1186/1758-2652-13-S4-O32 Text en Copyright ©2010 Rockstroh et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Baumgarten, A
Lutz, T
Kreckel, P
Wellmann, E
Alshuth, U
Mauss, S
Rockstroh, J
Efficacy and safety of peginterferon alfa-2a + RBV in cHCV/HIV- vs cHCV-infected patients: interim analysis of a multicenter German cohort
title Efficacy and safety of peginterferon alfa-2a + RBV in cHCV/HIV- vs cHCV-infected patients: interim analysis of a multicenter German cohort
title_full Efficacy and safety of peginterferon alfa-2a + RBV in cHCV/HIV- vs cHCV-infected patients: interim analysis of a multicenter German cohort
title_fullStr Efficacy and safety of peginterferon alfa-2a + RBV in cHCV/HIV- vs cHCV-infected patients: interim analysis of a multicenter German cohort
title_full_unstemmed Efficacy and safety of peginterferon alfa-2a + RBV in cHCV/HIV- vs cHCV-infected patients: interim analysis of a multicenter German cohort
title_short Efficacy and safety of peginterferon alfa-2a + RBV in cHCV/HIV- vs cHCV-infected patients: interim analysis of a multicenter German cohort
title_sort efficacy and safety of peginterferon alfa-2a + rbv in chcv/hiv- vs chcv-infected patients: interim analysis of a multicenter german cohort
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112846/
http://dx.doi.org/10.1186/1758-2652-13-S4-O32
work_keys_str_mv AT baumgartena efficacyandsafetyofpeginterferonalfa2arbvinchcvhivvschcvinfectedpatientsinterimanalysisofamulticentergermancohort
AT lutzt efficacyandsafetyofpeginterferonalfa2arbvinchcvhivvschcvinfectedpatientsinterimanalysisofamulticentergermancohort
AT kreckelp efficacyandsafetyofpeginterferonalfa2arbvinchcvhivvschcvinfectedpatientsinterimanalysisofamulticentergermancohort
AT wellmanne efficacyandsafetyofpeginterferonalfa2arbvinchcvhivvschcvinfectedpatientsinterimanalysisofamulticentergermancohort
AT alshuthu efficacyandsafetyofpeginterferonalfa2arbvinchcvhivvschcvinfectedpatientsinterimanalysisofamulticentergermancohort
AT mausss efficacyandsafetyofpeginterferonalfa2arbvinchcvhivvschcvinfectedpatientsinterimanalysisofamulticentergermancohort
AT rockstrohj efficacyandsafetyofpeginterferonalfa2arbvinchcvhivvschcvinfectedpatientsinterimanalysisofamulticentergermancohort

Ejemplares similares